184 related articles for article (PubMed ID: 36357795)
1. Subcutaneous octreotide therapy for malignant pleural effusion after pleurodesis with talc powder: a placebo-controlled, triple-blind, randomized trial.
Ershadi R; Vahedi M; Zadeh HK; Fathi F; Ebrahimpour H; Zadeh JS; Rafieian S
Support Care Cancer; 2022 Dec; 30(12):9833-9840. PubMed ID: 36357795
[TBL] [Abstract][Full Text] [Related]
2. Thoracoscopy and talc poudrage compared with intercostal drainage and talc slurry infusion to manage malignant pleural effusion: the TAPPS RCT.
Bhatnagar R; Luengo-Fernandez R; Kahan BC; Rahman NM; Miller RF; Maskell NA
Health Technol Assess; 2020 Jun; 24(26):1-90. PubMed ID: 32525474
[TBL] [Abstract][Full Text] [Related]
3. Interventions for the management of malignant pleural effusions: a network meta-analysis.
Clive AO; Jones HE; Bhatnagar R; Preston NJ; Maskell N
Cochrane Database Syst Rev; 2016 May; 2016(5):CD010529. PubMed ID: 27155783
[TBL] [Abstract][Full Text] [Related]
4. Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (±talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusion.
Fitzgerald DB; Sidhu C; Budgeon C; Tan AL; Read CA; Kwan BCH; Smith NA; Fysh ET; Muruganandan S; Saghaie T; Shrestha R; Badiei A; Nguyen P; Burke A; Goddard J; Windsor M; McDonald J; Wright G; Czarnecka K; Sivakumar P; Yasufuku K; Feller-Kopman DJ; Maskell NA; Murray K; Lee YCG
Trials; 2022 Jun; 23(1):530. PubMed ID: 35761341
[TBL] [Abstract][Full Text] [Related]
5. Interventions for the management of malignant pleural effusions: a network meta-analysis.
Dipper A; Jones HE; Bhatnagar R; Preston NJ; Maskell N; Clive AO
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD010529. PubMed ID: 32315458
[TBL] [Abstract][Full Text] [Related]
6. Talc pleurodesis as surgical palliation of patients with malignant pleural effusion. Analysis of factors affecting survival.
Lumachi F; Mazza F; Ermani M; Chiara GB; Basso SM
Anticancer Res; 2012 Nov; 32(11):5071-4. PubMed ID: 23155281
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions.
Kolschmann S; Ballin A; Gillissen A
Chest; 2005 Sep; 128(3):1431-5. PubMed ID: 16162739
[TBL] [Abstract][Full Text] [Related]
8. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial.
Davies HE; Mishra EK; Kahan BC; Wrightson JM; Stanton AE; Guhan A; Davies CW; Grayez J; Harrison R; Prasad A; Crosthwaite N; Lee YC; Davies RJ; Miller RF; Rahman NM
JAMA; 2012 Jun; 307(22):2383-9. PubMed ID: 22610520
[TBL] [Abstract][Full Text] [Related]
9. Effect of Thoracoscopic Talc Poudrage vs Talc Slurry via Chest Tube on Pleurodesis Failure Rate Among Patients With Malignant Pleural Effusions: A Randomized Clinical Trial.
Bhatnagar R; Piotrowska HEG; Laskawiec-Szkonter M; Kahan BC; Luengo-Fernandez R; Pepperell JCT; Evison MD; Holme J; Al-Aloul M; Psallidas I; Lim WS; Blyth KG; Roberts ME; Cox G; Downer NJ; Herre J; Sivasothy P; Menzies D; Munavvar M; Kyi MM; Ahmed L; West AG; Harrison RN; Prudon B; Hettiarachchi G; Chakrabarti B; Kavidasan A; Sutton BP; Zahan-Evans NJ; Quaddy JL; Edey AJ; Clive AO; Walker SP; Little MHR; Mei XW; Harvey JE; Hooper CE; Davies HE; Slade M; Sivier M; Miller RF; Rahman NM; Maskell NA
JAMA; 2020 Jan; 323(1):60-69. PubMed ID: 31804680
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety profile of autologous blood versus talc pleurodesis for malignant pleural effusion: a randomized controlled trial.
Keeratichananont W; Kaewdech A; Keeratichananont S
Ther Adv Respir Dis; 2018; 12():1753466618816625. PubMed ID: 30526440
[TBL] [Abstract][Full Text] [Related]
11. Role of thoracic ultrasonography in pleurodesis pathways for malignant pleural effusions (SIMPLE): an open-label, randomised controlled trial.
Psallidas I; Hassan M; Yousuf A; Duncan T; Khan SL; Blyth KG; Evison M; Corcoran JP; Barnes S; Reddy R; Bonta PI; Bhatnagar R; Kagithala G; Dobson M; Knight R; Dutton SJ; Luengo-Fernandez R; Hedley E; Piotrowska H; Brown L; Asa'ari KAM; Mercer RM; Asciak R; Bedawi EO; Hallifax RJ; Slade M; Benamore R; Edey A; Miller RF; Maskell NA; Rahman NM
Lancet Respir Med; 2022 Feb; 10(2):139-148. PubMed ID: 34634246
[TBL] [Abstract][Full Text] [Related]
12. Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion.
Ibrahim IM; Dokhan AL; El-Sessy AA; Eltaweel MF
J Cardiothorac Surg; 2015 May; 10():64. PubMed ID: 25947235
[TBL] [Abstract][Full Text] [Related]
13. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.
Stefani A; Natali P; Casali C; Morandi U
Eur J Cardiothorac Surg; 2006 Dec; 30(6):827-32. PubMed ID: 17113008
[TBL] [Abstract][Full Text] [Related]
14. Thoracic Ultrasound as an Early Predictor of Pleurodesis Success in Malignant Pleural Effusion.
Corcoran JP; Hallifax RJ; Mercer RM; Yousuf A; Asciak R; Hassan M; Piotrowska HE; Psallidas I; Rahman NM
Chest; 2018 Nov; 154(5):1115-1120. PubMed ID: 30243566
[TBL] [Abstract][Full Text] [Related]
15. Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial.
Thomas R; Fysh ETH; Smith NA; Lee P; Kwan BCH; Yap E; Horwood FC; Piccolo F; Lam DCL; Garske LA; Shrestha R; Kosky C; Read CA; Murray K; Lee YCG
JAMA; 2017 Nov; 318(19):1903-1912. PubMed ID: 29164255
[TBL] [Abstract][Full Text] [Related]
16. OPTIMUM: a protocol for a multicentre randomised controlled trial comparing Out Patient Talc slurry via Indwelling pleural catheter for Malignant pleural effusion vs Usual inpatient Management.
Sivakumar P; Douiri A; West A; Rao D; Warwick G; Chen T; Ahmed L
BMJ Open; 2016 Oct; 6(10):e012795. PubMed ID: 27798020
[TBL] [Abstract][Full Text] [Related]
17. Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.
Noro R; Kobayashi K; Usuki J; Yomota M; Nishitsuji M; Shimokawa T; Ando M; Hino M; Hagiwara K; Miyanaga A; Seike M; Kubota K; Gemma A;
Thorac Cancer; 2020 Jul; 11(7):1876-1884. PubMed ID: 32421226
[TBL] [Abstract][Full Text] [Related]
18. Pleurodesis for malignant pleural effusions.
Shaw P; Agarwal R
Cochrane Database Syst Rev; 2004; (1):CD002916. PubMed ID: 14973997
[TBL] [Abstract][Full Text] [Related]
19. Survival in patients with malignant pleural effusion undergoing talc pleurodesis.
Hassan M; Mercer RM; Maskell NA; Asciak R; McCracken DJ; Bedawi EO; Shaarawy H; El-Ganady A; Psallidas I; Miller RF; Rahman NM
Lung Cancer; 2019 Nov; 137():14-18. PubMed ID: 31521977
[TBL] [Abstract][Full Text] [Related]
20. Indwelling pleural catheter versus talc pleurodesis for malignant pleural effusion: a meta-analysis.
Yeung M; Loh EW; Tiong TY; Tam KW
Clin Exp Metastasis; 2020 Aug; 37(4):541-549. PubMed ID: 32524317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
